Immunoassays are bioanalytical techniques that measure the molecular concentration in the solution by use of antibody and antigen. The quantity of the analyte in the solution depends on the reaction of antigen and antibody. Immunoassay is popularly used to detect the presence of a specific substance in the human body such as pathogen, hormone, antigen, antibody or an enzyme. Immunoassays has applications in various fields including clinical chemistry. They are used pertaining to their attributes such as specificity, sensitivity, criticalness and rapid results. Beside diagnostics, immunoassays are also being used in R&D, and quality control in pharmaceutical & biotechnology and food & beverages industry, pharmaceutical analysis like disease diagnosis, therapeutic drug monitoring, drug efficacy, bioequivalence studies, clinical pharmacokinetics and pharmacodynamics in drug development and pharmaceutical industries.
The importance of immunoassay techniques is due to their inherent specificity, rapid detection and high-throughput for the analysis of wide range of substances in biological samples.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
- Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
- Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
- Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to automated immunoassay analyzer has been reduced and this segment have to face negligence subsequently causing negative impact on automated immunoassay analyzer market
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The rising prevalence of infectious and chronic diseases such as cancer, autoimmune disorders, growing geriatric population around the globe, has resulted in to high volumes of diagnostic tests aiding in the growth of the automated immunoassay analyzers industry. Rising demand toward lab automation and popularity of these products, due to immense funding related to R&D activities aimed toward providing innovative solutions and resolving issues to the current product portfolio and wide clinical applications would further surge the demand for automated immunoassay analyzers in the market over coming years. Technological developments in the field of efficient lab equipment will further fuel the global automated immunoassay analyzers market. Several pharmaceutical and biologics firms are increasingly using these detection mechanisms for drug discovery and development purpose.
However, the dearth of skilled professionals, the unavailability of healthcare providers in the emerging and underdeveloped regions is expected to hamper the market. Additionally, the stringent regulatory scenario and high capital investment in upgrading from conventional to advanced automated equipment would potentially cause hindrance in the industry growth. Furthermore, shrinking compensations for diagnostic laboratories in developed economies may have a negative impact on the market growth.
As the demand for automated immunoassay analyzers is on rise in developed regions, the emerging regions are likely to exhibit even higher demand for these products comparatively owing to rising disposable incomes and healthy government initiatives for the providing better healthcare facilities. This would result in creation of immense opportunities for the market expansion.
Increasing prevalence of chronic and infectious diseases and healthcare expenditure to boost the growth
According to the statistics published by the World Health Organization (WHO), there has been immense rise in chronic diseases worldwide. In 2001, chronic diseases accounted for almost 60% of the 56.5 million reported deaths with approximately 46% of the burden of disease worldwide. Non-communicable diseases (NCDs) are expected to increase up to 57% by 2020. The geriatric population is expected to rise by 22% by the year 2050, according to WHO. The number of infectious & non-infectious diseases has been rising simultaneously. According to the WHO, by 2018, the number of people infected with this virus is 75 million right from the beginning of this pandemic and around 32 million people have died because of this disease. Additionally, by the end of2018, around 37.9 million people were living with HIV. The growth in various diseases would ensure market development for this market.
Organization for Economic Co-operation and Development (OECD) survey report, stated in 2018 average per capita health expenditure in the U.S. was about $10,586. Thus, the rising healthcare expenditure would also contribute to the global immunoassay analyzers market.
The efforts taken to increase the accuracy of diagnostic results, increasing incidences of chronic diseases and increasing healthcare expenditure are factors that would facilitate the market growth.
North American region dominates the market
North America is expected to lead the automated immunoassay analyzers throughout. The dominance is due to factors like rise in the prevalence of chronic diseases and higher adoption of technology in the region. According to Centers for Disease Control and Prevention, cardiac diseases are a leading cause of death in American men. Drastic rise in healthcare expenditure and high strain to get better health outputs at lower costs, availability of a well-developed infrastructure and presence of major industry are the other factors fostering the market in the near future.
Key benefits of the report:
- This study presents the analytical depiction of the global automated immunoassay analyzers industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global automated immunoassay analyzers market share.
- The current market is quantitatively analyzed to highlight the global automated immunoassay analyzers market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global automated immunoassay analyzers market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the automated immunoassay analyzers market research report:
- Which are the leading market players active in the automated immunoassay analyzers market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Automated Immunoassay Analyzers Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Abbott,, Meril Life Sciences,, BioRad,, Roche Diagnostics,, Carolina Liquid Chemistries Corporation,, Aesku Diagnotics,, Perkin Elmer ., BioMerieux,, Becton Dickinson and Company,, Arlington Scientific, |
Loading Table Of Content...
